Menu

Blog

Feb 13, 2024

Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis

Posted by in category: biotech/medical

A meta-analysis of 39 studies showed that circulating tumor DNA presence is a prognosis factor for solid tumors after curative therapy. ctDNA has high specificity but low sensitivity. It had better accuracy in surveillance compared to landmark analyses.

Comments are closed.